Aflibercept (40 mg/ml)

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha·Praha, Czech Republic·CZK 50.1M | EUR 2.1M·Expired · Sep 15, 2026·Open·Supplies

High valueStructured notice only

Original notice title

Czechia – Ophthalmologicals – Aflibercept (40 mg/ml)

55/100

Opportunity Score

Needs reviewLow complexity

SuppliesExpired

Why this score?

Opportunity

55 / 100

Complexity

25 / 100

Risk factors

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Tender facts

Contracting authority: Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Country: Czech Republic
CPV: 33662100 - Ophthalmologicals
Deadline: Sep 15, 2026
Estimated value: CZK 50.1M (approx. EUR 2.1M)

Overview

Moderate opportunity

Key Facts

CZK 50.1M estimated value
Supplies contract
1 lot
Duration 48 MONTH
Continuous supplies of Aflibercept (40 mg/ml) for 48 months.
Delivery to Central Military Hospital – Military University Hospital Prague.

Show full summary

Open tender by Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha for continuous supplies of the medicinal product with active substance Aflibercept (40 mg/ml) for a period of 48 months. The estimated value is 50,148,102.56 CZK. Award based on lowest price. No selection criteria or procurement documents provided in the analysis.

Risks

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

Pharmaceutical product with active substance Aflibercept at concentration 40 mg/ml.
Contract duration 48 months.
EU-funded project (conflicting: XML notice states no EU funds).

Requirements may be incomplete.

Award Criteria

Lot 1

Lowest price (weight 100) — 100%

Buyer

Name

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha

Location

Praha, CZE

[email protected]

Website

www.uvn.cz

Buyer profile

Open profile

Identifier

61383082

Activity

Health

Lots (1)

LOT-0001